NDC Compounded Drug 83343-002-15
Injection, Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching
NDC crossover of Alpha Lipoic Acid with NDC 83343-002 a human compounded drug with other similar products matching the same substance name () and the same administration route (intravenous) or dosage form (injection, solution).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
26436-5002-1 | B6-fusion | Pyridoxine Hcl | 10 mL in 1 VIAL, MULTI-DOSE | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5002-1 | B6-fusion | Pyridoxine Hcl | 10 mL in 1 VIAL, MULTI-DOSE | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5055-3 | Nsi 9m | Methyl B12/ Mic/carnitine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5055-3 | Nsi 9m | Methyl B12/ Mic/carnitine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5084-3 | Biotin 10mg/ml | Biotin 10mg/ml | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5084-3 | Biotin 10mg/ml | Biotin 10mg/ml | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5084-3 | Biotin 10mg/ml | Biotin 10mg/ml | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5194-3 | Nsi 12 | Methyl B12/b-complex/ Mic/carnitine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5194-3 | Nsi 12 | Methyl B12/b-complex/ Mic/carnitine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5472-5 | Nad | Nicotinamide Adenine Dinucleotide | 5 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-5558-0 | Nad | Nicotinamide Adenine Dinucleotide 50mg | 10 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-5558-0 | Nad | Nicotinamide Adenine Dinucleotide 50mg | 10 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-5558-5 | Nad | Nicotinamide Adenine Dinucleotide 50mg | 5 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-5558-5 | Nad | Nicotinamide Adenine Dinucleotide 50mg | 5 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-5558-5 | Nad | Nicotinamide Adenine Dinucleotide 50mg | 5 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-5575-3 | Ic B-com Cl | Cyano B12/b-complex/ic/carnitine/leucine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5575-3 | Ic B-com Cl | Cyano B12/b-complex/ic/carnitine/leucine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5576-3 | Mic B-com Ca | B-complex/mic/carnitine/arginine/lidocaine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5576-3 | Mic B-com Ca | B-complex/mic/carnitine/arginine/lidocaine | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5580-1 | Phenol | Phenol | 10 mL in 1 VIAL | Injection, Solution | Intradermal | Hybrid Pharma |
26436-5580-1 | Phenol | Phenol | 10 mL in 1 VIAL | Injection, Solution | Intradermal | Hybrid Pharma |
26436-5580-1 | Phenol | Phenol | 10 mL in 1 VIAL | Injection, Solution | Intradermal | Hybrid Pharma |
26436-5589-3 | Nsi 6 | Mic/carnitine/b1/b5 | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-5589-3 | Nsi 6 | Mic/carnitine/b1/b5 | 30 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular | Hybrid Pharma |
26436-6000-1 | Sodium Chloride | Sodium Chloride | 10 mL in 1 VIAL, GLASS | Injection, Solution | Intramuscular; Intravenous | Hybrid Pharma |
26436-6001-1 | Potassium Chloride PF | Potassium Chloride | 10 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
26436-6018-1 | Aminophylline | Aminophylline | 10 mL in 1 VIAL | Injection, Solution | Intravenous | Hybrid Pharma |
54288-821-01 | Iso Sulfan Blue 1% (10 Mg/ml) | Iso Sulfan Blue 1% (10 Mg/ml) | 1 mL in 1 CARTON | Injection, Solution | Subcutaneous | Bpi Labs Llc |
61141-1137-4 | Ephedrine Sulfate 25mg/5ml (5mg/ml) | Ephedrine Sulfate | 5 mL in 1 SYRINGE | Injection, Solution | Intravenous | Medi-fare Drug |
61141-1318-1 | Fentanyl Citrate 2500mcg/250ml (10mcg/ml) Bag | Fentanyl Citrate Drip | 250 mL in 1 BAG | Injection, Solution | Intravenous | Medi-fare Drug |
Frequently Asked Questions
What is the NDC number assigned to Fentanyl Citrate 2500mcg/250ml (10mcg/ml) Bag?
Fentanyl Citrate 2500mcg/250ml (10mcg/ml) Bag was assigned by its manufacturer with NDC product code 83343-002. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Fentanyl Citrate 2500mcg/250ml (10mcg/ml) Bag?
The NDC package code 83343-002-15 was assigned to a 5447 mL in 1 VIAL of administered intravenous via injection, solution.
Who manufactures this product?
Fentanyl Citrate 2500mcg/250ml (10mcg/ml) Bag is manufactured by an outsourced facility and labeled by Mcguff Outsourcing Solutions Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma, BPI Labs LLC and Medi-Fare Drug with NDC product codes 26436-5002-1, 26436-5002-1, 26436-5055-3, 26436-5055-3, 26436-5084-3, 26436-5084-3, 26436-5084-3, 26436-5194-3, 26436-5194-3, 26436-5472-5, 26436-5558-0, 26436-5558-0, 26436-5558-5, 26436-5558-5, 26436-5558-5, 26436-5575-3, 26436-5575-3, 26436-5576-3, 26436-5576-3, 26436-5580-1, 26436-5580-1, 26436-5580-1, 26436-5589-3, 26436-5589-3, 26436-6000-1, 26436-6001-1, 26436-6018-1, 54288-821-01, 61141-1137-4 and 61141-1318-1.